| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
TECH
Bio-Techne
|
Aug 08, 2025 | BUY |
Strong Buy
+38.6% avg upside
21 analysts
|
$75.00
29.39% Upside
|
+11.8% |
|
WAT
Waters
|
Aug 06, 2025 | BUY |
Strong Buy
+3.5% avg upside
30 analysts
|
$465.00
30.81% Upside
|
+28.8% |
|
ILMN
Illumina
|
Aug 05, 2025 | HOLD |
Buy
-10.0% avg upside
30 analysts
|
$125.00
22.77% Downside
|
+62.7% |
|
GH
Guardant Health
|
Jul 31, 2025 | BUY |
Strong Buy
-5.8% avg upside
30 analysts
|
$60.00
54.46% Downside
|
+215.1% |
|
TMO
Thermo Fisher
|
Jul 28, 2025 | BUY |
Strong Buy
+26.9% avg upside
38 analysts
|
$590.00
27.03% Upside
|
-4.5% |
|
DHR
Danaher
|
Jul 23, 2025 | BUY |
Strong Buy
+21.8% avg upside
45 analysts
|
$275.00
55.20% Upside
|
-7.9% |
|
VCYT
Veracyte
|
May 21, 2025 | BUY |
Strong Buy
-19.0% avg upside
17 analysts
|
$44.00
17.87% Downside
|
+39.4% |
|
BDSX
Biodesix
|
May 21, 2025 | BUY |
Strong Buy
+92.6% avg upside
8 analysts
|
$40.00
138.00% Upside
|
+92.2% |
|
CSTL
Castle Biosciences
|
May 21, 2025 | BUY |
Strong Buy
+98.2% avg upside
9 analysts
|
$40.00
89.46% Upside
|
+19.4% |
|
MYGN
Myriad Genetics
|
May 20, 2025 | HOLD |
Hold
+315.3% avg upside
24 analysts
|
$6.00
32.21% Upside
|
-14.4% |
|
TWST
Twist Bioscience
|
May 06, 2025 | BUY |
Strong Buy
-25.5% avg upside
14 analysts
|
$62.00
29.15% Downside
|
+81.8% |
|
ADPT
Adaptive Biotechnologies
|
May 05, 2025 | BUY |
Strong Buy
+20.0% avg upside
14 analysts
|
$12.00
31.58% Downside
|
+37.4% |
|
PACB
Pacific Biosciences
|
Apr 10, 2025 | BUY |
Buy
+214.0% avg upside
14 analysts
|
$2.00
42.96% Upside
|
-2.9% |
|
BNGO
BioNano Genomics
|
Apr 02, 2025 | HOLD |
Strong Buy
+724.8% avg upside
9 analysts
|
$4.00
250.81% Upside
|
-68.0% |
|
QTRX
Quanterix
|
Mar 25, 2025 | BUY |
Buy
+464.7% avg upside
8 analysts
|
$18.00
430.96% Upside
|
-43.6% |
|
CDNA
CareDx
|
Aug 19, 2024 | BUY |
Buy
+26.1% avg upside
16 analysts
|
$40.00
52.88% Upside
|
-66.0% |
|
TKNO
Alpha Teknova
|
Mar 16, 2022 | BUY |
Strong Buy
+176.5% avg upside
7 analysts
|
$28.00
434.39% Upside
|
-77.7% |
|
LAB
Standard BioTools
|
Feb 23, 2022 | BUY |
Strong Buy
+645.1% avg upside
8 analysts
|
$6.00
623.21% Upside
|
-43.9% |
|
BRKR
Bruker
|
Feb 22, 2022 | BUY |
Buy
-7.0% avg upside
22 analysts
|
$98.00
71.29% Upside
|
+4.2% |
|
BIORQ
Biora Therapeutics
|
May 17, 2021 | BUY |
Strong Buy
+269249900.0% avg upside
6 analysts
|
$12.00
11999900.01% Upside
|
· |
|
FLGT
Fulgent Genetics
|
May 12, 2021 | HOLD |
Buy
+143.4% avg upside
7 analysts
|
— | -22.8% |
|
CERS
Cerus
|
May 09, 2018 | HOLD |
Strong Buy
+99.1% avg upside
10 analysts
|
— | -12.6% |
|
MTD
Mettler-Toledo
|
May 08, 2015 | BUY |
Buy
+2.7% avg upside
18 analysts
|
$350.00
69.43% Downside
|
+9.5% |
|
CRL
Charles River Labs
|
Apr 29, 2015 | BUY |
Strong Buy
+12.0% avg upside
34 analysts
|
$78.00
57.84% Downside
|
+4.0% |
|
ROSGQ
Rosetta Genomics
|
Apr 17, 2015 | BUY |
Buy
+449999900.0% avg upside
4 analysts
|
$5.50
549999900.02% Upside
|
· |
|
CRDF
Cardiff Oncology
|
Mar 27, 2015 | BUY |
Strong Buy
+736.8% avg upside
18 analysts
|
$8.00
561.17% Upside
|
-25.7% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.